El Butlletí de la Recerca es fa ressò de les publicacions indexades a la Web of Science i a Scopus, però també podeu fer-nos arribar les vostres publicacions a través de l’URecerca – Gestió de la Producció Científica que trobareu al Campus Virtual.
Tobacco imagery in prime-time television in Spain: A content analysis
Peruga, A., Tigova, O., Feliu, A., Carnicer-Pont, D., Anton, L., Bosch, F., Rey-Pino, J. M., Salto, E., Fernández, E., & … Read More
Systematic Literature Review of Decision-Analytic Modeling Studies on Nature-Based Social Prescribing and Loneliness
Rochau, U., Papon, V., Stojkov, I., Kuehne, F., Arvandi, M., Conrads-Frank, A., Schmid, D., Jahn, B., Santamaria Navarro, J., Suzumura, … Read More
The Impact of Assessment Schedules on Intimate Partner Violence Reporting in Young Adults
Lorber, M. F., Smith Slep, A. M., Kim, S., Heyman, R. E., Cantor, D. C., Fisher, B. S., Segura, A., … Read More
Traducció, dones i llengües minoritzades de Sardenya
Floris, F. E. (2025). Traducció, dones i llengües minoritzades de Sardenya. Quaderns. Revista de Traducció, 32, 223–236. https://doi.org/10.5565/rev/quaderns.128
Carme Montoriol, traductora de poesia japonesa
Coll Mariné, M. (2025). Carme Montoriol, traductora de poesia japonesa. Quaderns. Revista de Traducció, 32, 169–185. https://doi.org/10.5565/rev/quaderns.130
L’activitat traductora de Manuel Reventós Bordoy. Una restitució i uns inèdits
Reventós, L., & Llanas, M. (2025). L’activitat traductora de Manuel Reventós Bordoy. Una restitució i uns inèdits. Quaderns, Revista de … Read More
Managing diabetes across female reproductive stages
Mauricio, D., Gratacòs, M., & Franch-Nadal, J. (2025). Managing diabetes across female reproductive stages. Trends in Endocrinology and Metabolism, 36(5), … Read More
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer
Elez, E., Yoshino, T., Shen, L., Lonardi, S., Van Cutsem, E., Eng, C., Tabernero, J., …Investigators, B. T. (2025). Encorafenib, … Read More
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
Janjigian, Y., Al-Batran, S., Wainberg, Z., Muro, K., Molena, D., Van Cutsem, E., Tabernero, J., …Investigators, M. (2025). Perioperative Durvalumab … Read More
Poor side-to-side symmetry limits the use of the contralateral limb as a reliable reference for guiding coronal positioning and alignment in total knee arthroplasty
Pujol, O., Hinarejos, P., Pons, A., Famada, E., Zumel, A., Erquicia, J., & Leal-Blanquet, J. (2025). Poor side-to-side symmetry limits … Read More
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial
Taieb, J., Fakih, M., Tabernero, J., Ciardiello, F., Van Cutsem, E., Soler, G.,…Prager, G. (2025). Impact of Treatment With Trifluridine/Tipiracil … Read More
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Luke, J., Gelmon, K., Siu, L., Moreno, V., Desai, J., Gomez-Roca, C.,…Tabernero, J. (2025). Phase 1/2 Study of the Indoleamine … Read More
Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort
Jiménez-Sánchez, A., Moreno-Arrones, O., Béa-Ardebol, S., Mayo-Martínez, F., Pérez-Pastor, G., Torres-Navarro, I.,…Rodriguez-Jiménez, P. (2025). Response to Sonidegib in Advanced Basal … Read More
The People-First Liver Charter
Lazarus, J., Wajcman, D., Pannain, S., Brennan, P., Manolas, M., Jepsen, P.,…Villota-Rivas, M. (2025). The People-First Liver Charter. Nature Medicine. … Read More
Blood-based biomarkers in centenarians and non-centenarians: a matched, population-based retrospective cohort study using primary care records in Catalonia, Spain
Moreno, M., Vidal-Alaball, J., Saez, M., & Barceló, M. (2025b). Blood-based biomarkers in centenarians and non-centenarians: a matched, population-based retrospective … Read More
The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER study: A plain language summary
Kopetz, S., Yoshino, T., Van Cutsem, E., Eng, C., Kim, T. W., Wasan, H. S., Desai, J., Ciardiello, F., Yaeger, … Read More
Why ponds concentrate nutrients: The roles of internal features, land use, and climate
Bartrons, M., Yang, J., Cuenca‑Cambronero, M., Lemmens, P., Anton-Pardo, M., Beklioğlu, M., Biggs, J., Boissezon, A., Boix, D., Calvo, C., … Read More
Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications
Lundberg, A., Geuijen, C., Hill, S., van Bueren, J., Fumagalli, A., de Kruif, J.,…Tabernero, J. (2025). Petosemtamab, a Bispecific Antibody … Read More